Cargando…

Increased levels of YKL-40 in patients with diabetes mellitus: a systematic review and meta-analysis

BACKGROUND: Diabetes mellitus (DM) could be classified as type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), gestational diabetes mellitus (GDM) and others according to etiology and pathology. Diabetic nephropathy (DN) is one of the most serious complications of DM. YKL-40 is a marker...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Wanwan, Zhang, Lingmin, Sheng, Lingling, Zhang, Zhencheng, Yang, Zaixing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809835/ https://www.ncbi.nlm.nih.gov/pubmed/33446257 http://dx.doi.org/10.1186/s13098-021-00624-9

Ejemplares similares

Peripheral Blood and Cerebrospinal Fluid Levels of YKL-40 in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
por: Zhang, Yuchen, et al.
Publicado: (2023)

YKL-40 levels are independently associated with albuminuria in type 2 diabetes
por: Røndbjerg, Anne K, et al.
Publicado: (2011)

Increased serum YKL-40 level is associated with the presence and severity of metabolic syndrome
por: Akboğa, Mehmet Kadri, et al.
Publicado: (2016)

Increased YKL-40 but Not C-Reactive Protein Levels in Patients with Alzheimer’s Disease
por: Blanco-Palmero, Víctor Antonio, et al.
Publicado: (2021)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

Increased Levels of Chitotriosidase and YKL-40 in Cerebrospinal Fluid from Patients with Alzheimer's Disease
por: Rosén, Christoffer, et al.
Publicado: (2014)

Increased YKL-40 levels are linked with disease severity of initially diagnosed Graves’ disease
por: Chen, Yi-Ding, et al.
Publicado: (2023)

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review
por: Tong, Xiang, et al.
Publicado: (2018)

Increased immunohistochemical expression of YKL-40 in the spleen of patients with portal hypertension
por: Wang, Dong, et al.
Publicado: (2012)

YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria
por: Rathcke, Camilla Noelle, et al.
Publicado: (2009)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

YKL-40 tissue expression and plasma levels in patients with ovarian cancer
por: Høgdall, Estrid VS, et al.
Publicado: (2009)

Serum YKL-40 levels and disease characteristics in patients with rheumatoid arthritis
por: Jafari-Nakhjavani, Mohammad Reza, et al.
Publicado: (2019)

Serum YKL-40 Levels Are Associated with the Atherogenic Index of Plasma in Children
por: Kwon, Yoowon, et al.
Publicado: (2020)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

A polymorphism associated with increased levels of YKL-40 and the risk of early onset of lone atrial fibrillation
por: Henningsen, Kristoffer M A, et al.
Publicado: (2013)

Can YKL-40 be used as a biomarker for interstitial lung disease?: A systematic review and meta-analysis
por: Tong, Xiang, et al.
Publicado: (2021)

Prognostic value of YKL-40 in colorectal carcinoma patients: A meta-analysis
por: Wang, Jian, et al.
Publicado: (2022)

Serum YKL-40 Levels and White Matter Hyperintensities in Patients with Acute Ischemic Stroke
por: Shi, Guomei, et al.
Publicado: (2023)

Serum YKL-40 Levels and Chitotriosidase Activity in Patients with Beta-Thalassemia Major
por: Musumeci, Maria, et al.
Publicado: (2014)

Plasm YKL-40 Levels Are Associated with Hypertension in Patients with Obstructive Sleep Apnea
por: Li, Kun, et al.
Publicado: (2019)

Serum YKL-40 Levels in Patients with Asthma or COPD: A Pilot Study
por: Popețiu, Romana Olivia, et al.
Publicado: (2023)

Cerebrospinal fluid YKL‐40 level evolution is associated with autoimmune encephalitis remission
por: Dorcet, Guillaume, et al.
Publicado: (2023)

Serum YKL-40 Levels, Leukocyte Profiles, and Acute Exacerbations of Advanced COPD
por: Popețiu, Romana Olivia, et al.
Publicado: (2023)

YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children
por: Yang, Xingge, et al.
Publicado: (2018)

Plasma YKL-40: A BMI-Independent Marker of Type 2 Diabetes
por: Nielsen, Anders R., et al.
Publicado: (2008)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

Circulating miRNA-24 and its target YKL-40 as potential biomarkers in patients with coronary heart disease and type 2 diabetes mellitus
por: Deng, Xin, et al.
Publicado: (2017)

Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus
por: Kim, Hyun Min, et al.
Publicado: (2012)

Diagnostic Performance of Biomarkers Urinary KIM-1 and YKL-40 for Early Diabetic Nephropathy, in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
por: Kapoula, Georgia V., et al.
Publicado: (2020)

Cancer risk by combined levels of YKL-40 and C-reactive protein in the general population
por: Allin, K H, et al.
Publicado: (2012)

Relationship between plasma YKL-40 levels and endothelial dysfunction in chronic kidney disease
por: KESKİN, Gül Sema, et al.
Publicado: (2019)

Elevated plasma YKL-40 level is found in the dogs with cancer and is related to poor prognosis
por: Cheng, Kai-Chung, et al.
Publicado: (2019)

Plasma levels of YKL-40 as a prognostic factor in childhood acute lymphoblastic leukemia
por: Rivas-Alarcón, Alinne Ayulieth, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vsaar6eh6cfp4rgvodpci8irth